The fungus has been the subject of research to test its anti-cancer efficacy in Professor Fuad Fares' laboratory at the University of Haifa for about eight years.

It was selected as the preferred candidate for the development of a drug for pancreatic and colon cancer after showing better anti-cancer results than a variety of other fungi tested.

A few months ago, the biomedical company Cannabotech received global and exclusive rights of use for patents created in Prof. Fares' research and began leading an accelerated process of developing a botanical drug as defined by the FDA.